Abstract:Our objective to study the expression and activity of the apoptosis protease Caspase-3 in E. coli BL21 (DE3) Plyss. The cDNA of Caspase-3 was amplified by PCR and inserted into the cell of K562, it was then cloned to prokaryotic expression vector pET-21b, after which Caspase-3 was induced by IPTG. The Protein induced was identified by SDS-PAGE and Western blot. After induced by IPTG for 5 hours, the concentration of Caspase-3 reached the highest level. Finally active Caspase-3 can be induced within E. coli BL21 (DE3) Plyss, further research can be done to chose the Caspase-3 inhibitors.
Introduction
Caspases play important roles in apoptosis and cell signaling. Caspase-3 is the core of the execution phase of apoptosis [1] . Caspase-3 has become attractive target in the treatment of many disease such as Alzheimer [2] ，Parkinson's [3] , myocardial infarction [4] and cancer [5] . Thus, key apoptosis factors serve as attractive molecular targets for designing specific pharmaceuticals for apoptosis diseases [6] . So Caspase-3 is identified as a drug-screening target. Caspase inhibitors have anti-cancer and other pharmalogical potentials. It has been proven that Caspase-3 substrate selectivity for the peptide sequence Asp-Glu-Val-Asp (DEVD) [7] . Our strategy was to establish Caspase-3 inhibitor rapid screening platform and Ac-DEVE-CHO [8] [9] [10] can be used as a control.
Materials and methods

Plasmid construction.
Human Caspase-3 full-length cDNA was amplified by the cell of K562. cDNA was used as a template for PCR amplification of the region in the open reading frame encoding the mature human Caspase-3. PCR amplification was performed using 25 ng of template DNA, 0.1 ng of the appropriate primers [5'-GCGAATTCATGGAGAACACTGAAAAC -3' (5'-primer) and 5 ' -GCGCGGCCGCTTAGTGATAAAAATAGAG-3'(3'-primer)], and 1U of Pfu turbo DNA polymerase (Stratagene) in a final reaction volume of 20 μL.The reaction mixture was subjected to amplification for 35 cycles (94 C, 0.5 min;55 C, 0.5 min; 72 C, 1.5 min) using a thermal cycler. The result of Caspase-3 PCR is shown in Fig.1 . After purification, PCR products were cleaved with EcoRI and NotI and ligated between the corresponding restriction sites of the vector pET-21b .This vector has a His-tag coding sequence and can produce a C-terminal 6 His-tag fusion protein. double digestion products of fragment Caspase-3 and vector connection at 16 ˚C overnight 。Then the ligation product was transformed into competent in E.col top 10 Screening of positive transformants were used to induce the expression of Caspase-3 protein and then to study the function and activity of other aspects.
Expression of the recombinant human Caspase-3
To express the recombinant human Caspase-3, E. coli BL21(DE3) Plyss cells were grown in LB medium (1 % bactotryptone,0.5 % yeast extract, 0.5 % NaCl) containing 100 μg/mL ampicillin at 37 ˚C to OD600 nm = 0.6-0.8.Isopropyl β-D-1-thiogalactopyranoside (IPTG) was then added to a final concentration of 1 mM and cells were further incubated for 1h-5h at 16 ˚C. The result of SDS-PAGE analysis was used to determine the optimal conditions for the expression of Caspase-3.
Purification of caspase-3.
Single colonies were used to inoculate a 5ml LB medium, containing the appropriate antibiotic and were then grown at 37 ˚C overnight. This culture was used to inoculate 50 ml of LB medium (added in 50 μL Ampicillin) at 37 ˚C to OD 600 nm = 0.6. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was then added to a final concentration of 1 mM and cells were further incubated for 5h at 16˚C. The inclusion bodies of Caspase-3 were prepared by cell lysis in a buffer containing 20 mM Tris-HCl (pH 8.0), 500 mM NaCl. Cells were broken using an noise isolating tamber (Ningbo Scienfz Biotechnology Co, LTD). The protein were supernatant by centrifugation at 5000×g for 5 min at 4 ˚C and loaded on a Ni2+-nitrilotriacetic acid at 4 ˚C over night. The Caspase-3 was eluted using a buffer containing 20 mM Tris-HCl (pH 8.0), 500 mM NaCl, 150mM imidazole. Fractions containing the Caspase-3 proteins were concentrated by Dialysis at 4 ˚C overnight ( Na 2 HPO 4 ·12H 2 O 16.692g,Na 2 H 2 PO 4 ·2H 2 O 0.53g,NaCl 5.844g,Glycerin100ml and water 900 ml). And then Caspase-3 were supernatant by centrifugation at 5000×g for 5 min at 4 ˚C.
caspase-3 activity assay
For determination of inhibitor potency against the purified enzyme, inhibitors were titrated against recombinant Caspase-3 and the enzyme activity was measured by Caspase-3 activity assay kits（Tianjin Sungene Biotech Co.,Ltd） 
Results and discussion
Expression and purification Caspase-3
The optimum conditions of the expression human caspase-3 is : 1 mM IPTG induced 5h at 16˚C.After IPTG induction, Caspase-3 was expressed as a major protein at 31 kDa in the total protein of E. coli, as shown in Fig. 2 . The size of expressed Caspase-3 was in good agreement with the theoretical molecular weight from the amino acid sequence of the lec-EGF domains and 6 His-tag. The protein was expressed mainly as soluble protein. After sonication Caspase-3 protein sample was purified by single step Ni 2+ affinity chromatography with the purification tags. The result of SDS-PAGE analysis for the purification of Caspase-3 is shown in Fig. 3 . The molecular weight of the soluble protein was evaluated as about 31 kDa. To determine the in vitro inhibitory potencies of Ac-DEVE-CHO toward Caspase-3, the recombinant enzyme was preincubated on ice in 20 mM HEPES,0.1 M NaCl,10% sucrose,0.1% CHAPS and 2 mM EDTA(pH 7.4) and the final concentration of the Caspase-3 is 5 ng/ml. The increasing concentrations of Ac-DEVE-CHO's final concentration is 0.1 nM,0.3 nM,1 nM,3 nM,10 Nm,30 nM wereadded . The percentage of cleavage was evaluated and compared with 100% relative activity,and the IC50 value was determined accordingly. By calculating the IC50 value of the Ac-DEVE-CHO is 2.28±0.05.
Conclusion
In this study, simplified and efficient Caspase-3 assay was established. Our work has shown that the Ac-DEVE-CHO has strong Caspase-3 inhibitory activity. In the next study, Ac-DEVE-CHO can be used as a Caspase-3 inhibitor screening test control. This study may provide valuable information for development of inhibiting apoptosis with more potent activities.
